CEO Dan Dischner highlighted the company’s recognition by the FDA with the Drug Shortage Assistance Award, acknowledging its efforts in mitigating critical drug shortages. He noted that the company’s ...
Management reiterated its guidance for flat revenue growth in 2025, supported by anticipated sales contributions from at least two of its pipeline products later in the year. Products AMP-002, AMP-007 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback